We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03550183
Recruitment Status : Enrolling by invitation
First Posted : June 8, 2018
Last Update Posted : December 30, 2021
Information provided by (Responsible Party):
Shengjun An, Hebei Newtherapy BIo-Pharma technology Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : October 10, 2022
Estimated Study Completion Date : December 30, 2022